Showing results (8011-8020 of 45,234) with videos related to
Sort By:
Pageof 4,524
Cancer Research|April 1, 1991
Radiotherapy in mice with yttrium-90-labeled anti-Ly1 monoclonal antibody: therapy of established graft-versus-host disease induced across the major histocompatibility barrierD A Vallera, H Schmidberger, D J Buchsbaum, et al.Cancer Research|April 1, 1991
Extracellular matrix and androgen receptor expression associated with spontaneous transformation of rat prostate fibroblastsM R Freeman, Y Song, D D Carson, et al.Cancer Research|April 1, 1991
Characterization of early kidney lesions in estrogen-induced tumors in the Syrian hamsterT D Oberley, A Gonzalez, L J Lauchner, et al.Cancer Research|April 1, 1991
Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancerY Aoki, K Takakuwa, S Kodama, et al.Cancer Research|January 6, 2010
Altered expression of neurotensin receptors is associated with the differentiation state of prostate cancerStephanie L Swift, Julie E Burns, Norman J MaitlandCancer Research|December 24, 2009
Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteineMinu K Srivastava, Pratima Sinha, Virginia K Clements, et al.Cancer Research|December 24, 2009
CCL2 blockade augments cancer immunotherapyZvi G Fridlender, George Buchlis, Veena Kapoor, et al.Cancer Research|December 24, 2009
Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patternsMarkus Schmitt, Véronique Dalstein, Tim Waterboer, et al.Cancer Research|December 24, 2009
OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomasDavid C Adamson, Qun Shi, Matthew Wortham, et al.Cancer Research|December 24, 2009
Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasivenessSrinivasulu Chigurupati, Rajarajeswari Venkataraman, Daniel Barrera, et al.Pageof 4,524